Treatment and outcomes in adolescents with schizophrenia

S. Charles Schulz, Robert L Findling, Lee Friedman, John T. Kenny, Alexandria L. Wise

Research output: Contribution to journalArticle

Abstract

The pharmacologic treatment and assessment of outcomes in adolescents with schizophrenia have been inadequately addressed. Structural brain imaging and brain function studies both point to a continuity between adolescent and adult stages of schizophrenia. Because the teenage population seems to be less tolerant of physical side effects, the advent of atypical antipsychotic medications may offer increased safety and efficacy. Studies support the notion that adolescent illness is associated with a more severe form of schizophrenia and that length of illness before treatment is correlated with long-term outcome. As a consequence, the authors recommend assertive pharmacologic intervention in adolescents with schizophrenia and future research focused on the issues of treatment and outcome in teenagers suffering a psychotic disorder.

Original languageEnglish (US)
Pages (from-to)50-56
Number of pages7
JournalJournal of Clinical Psychiatry
Volume59
Issue numberSUPPL. 1
StatePublished - 1998
Externally publishedYes

Fingerprint

Schizophrenia
Neuroimaging
Psychotic Disorders
Antipsychotic Agents
Safety
Brain
Population
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Schulz, S. C., Findling, R. L., Friedman, L., Kenny, J. T., & Wise, A. L. (1998). Treatment and outcomes in adolescents with schizophrenia. Journal of Clinical Psychiatry, 59(SUPPL. 1), 50-56.

Treatment and outcomes in adolescents with schizophrenia. / Schulz, S. Charles; Findling, Robert L; Friedman, Lee; Kenny, John T.; Wise, Alexandria L.

In: Journal of Clinical Psychiatry, Vol. 59, No. SUPPL. 1, 1998, p. 50-56.

Research output: Contribution to journalArticle

Schulz, SC, Findling, RL, Friedman, L, Kenny, JT & Wise, AL 1998, 'Treatment and outcomes in adolescents with schizophrenia', Journal of Clinical Psychiatry, vol. 59, no. SUPPL. 1, pp. 50-56.
Schulz SC, Findling RL, Friedman L, Kenny JT, Wise AL. Treatment and outcomes in adolescents with schizophrenia. Journal of Clinical Psychiatry. 1998;59(SUPPL. 1):50-56.
Schulz, S. Charles ; Findling, Robert L ; Friedman, Lee ; Kenny, John T. ; Wise, Alexandria L. / Treatment and outcomes in adolescents with schizophrenia. In: Journal of Clinical Psychiatry. 1998 ; Vol. 59, No. SUPPL. 1. pp. 50-56.
@article{5641b88e982649b3b8cf538c9f507e32,
title = "Treatment and outcomes in adolescents with schizophrenia",
abstract = "The pharmacologic treatment and assessment of outcomes in adolescents with schizophrenia have been inadequately addressed. Structural brain imaging and brain function studies both point to a continuity between adolescent and adult stages of schizophrenia. Because the teenage population seems to be less tolerant of physical side effects, the advent of atypical antipsychotic medications may offer increased safety and efficacy. Studies support the notion that adolescent illness is associated with a more severe form of schizophrenia and that length of illness before treatment is correlated with long-term outcome. As a consequence, the authors recommend assertive pharmacologic intervention in adolescents with schizophrenia and future research focused on the issues of treatment and outcome in teenagers suffering a psychotic disorder.",
author = "Schulz, {S. Charles} and Findling, {Robert L} and Lee Friedman and Kenny, {John T.} and Wise, {Alexandria L.}",
year = "1998",
language = "English (US)",
volume = "59",
pages = "50--56",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Treatment and outcomes in adolescents with schizophrenia

AU - Schulz, S. Charles

AU - Findling, Robert L

AU - Friedman, Lee

AU - Kenny, John T.

AU - Wise, Alexandria L.

PY - 1998

Y1 - 1998

N2 - The pharmacologic treatment and assessment of outcomes in adolescents with schizophrenia have been inadequately addressed. Structural brain imaging and brain function studies both point to a continuity between adolescent and adult stages of schizophrenia. Because the teenage population seems to be less tolerant of physical side effects, the advent of atypical antipsychotic medications may offer increased safety and efficacy. Studies support the notion that adolescent illness is associated with a more severe form of schizophrenia and that length of illness before treatment is correlated with long-term outcome. As a consequence, the authors recommend assertive pharmacologic intervention in adolescents with schizophrenia and future research focused on the issues of treatment and outcome in teenagers suffering a psychotic disorder.

AB - The pharmacologic treatment and assessment of outcomes in adolescents with schizophrenia have been inadequately addressed. Structural brain imaging and brain function studies both point to a continuity between adolescent and adult stages of schizophrenia. Because the teenage population seems to be less tolerant of physical side effects, the advent of atypical antipsychotic medications may offer increased safety and efficacy. Studies support the notion that adolescent illness is associated with a more severe form of schizophrenia and that length of illness before treatment is correlated with long-term outcome. As a consequence, the authors recommend assertive pharmacologic intervention in adolescents with schizophrenia and future research focused on the issues of treatment and outcome in teenagers suffering a psychotic disorder.

UR - http://www.scopus.com/inward/record.url?scp=0031933685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031933685&partnerID=8YFLogxK

M3 - Article

C2 - 9448669

AN - SCOPUS:0031933685

VL - 59

SP - 50

EP - 56

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - SUPPL. 1

ER -